Viking Global Investors
PRCT icon

Viking Global Investors’s Procept Biorobotics PRCT Stock Holding History

Viking Global Investors’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,545,000
Closed -$50.5M – 99
2022
Q2 		$50.5M Sell
1,545,000
-2,113,892
-58% -$76.9M 0.23% 68
2022
Q1 		$128M Sell
3,658,892
-1,249,000
-25% -$30.1M 0.52% 51
2021
Q4 		$123M Hold
4,907,892
– – 0.35% 68
2021
Q3 		$187M Buy
+4,907,892
New +$188M 0.51% 56

Other funds holding PRCT

CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Viking Global Investors's PRCT Position: Q3 2022 in Review

Viking Global Investors sold out of Procept Biorobotics (PRCT) in Q3 2022, closing a stake of 1,545,000 shares — an estimated $50.5M sold.

Viking Global Investors first reported a position in PRCT in Q3 2021 and held it in 4 quarters. The position peaked at $187M in Q3 2021. 103 funds tracked by Wall St. Rank hold PRCT as of Q3 2022.

  • Viking Global Investors reported no remaining Procept Biorobotics position as of Q3 2022 after selling out during the quarter.
  • Viking Global Investors sold 1,545,000 Procept Biorobotics shares in Q3 2022, an estimated $50.5M.
  • Viking Global Investors first reported a position in Procept Biorobotics in Q3 2021 and held it in 4 quarters.
  • Viking Global Investors's Procept Biorobotics position peaked at $187M in Q3 2021.
  • 103 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2022.

Based on Viking Global Investors's 13F filing for Q3 2022, filed 14 Nov 2022.